Skip to content

Artificial intelligence-guided discovery of marine scalaranes as selective COX-2 inhibitors through machine learning and molecular modelling.

Aug 2026 · Organic and biomolecular chemistry · Vol 24, pp. 7061-7075 · 0 citations
Medicine

TL;DR

An integrated artificial intelligence (AI) and molecular modeling pipeline to discover safer alternatives from the Red Sea sponge Hyrtios erectus is presented, offering a potential socio-economic breakthrough in the development of cost-effective, safer anti-inflammatory therapeutics derived from marine biodiversity.

Abstract

Anti-inflammatory agents are critical for managing chronic conditions, yet traditional non-selective inhibitors often lead to severe gastrointestinal or cardiovascular events. This study presents an integrated artificial intelligence (AI) and molecular modeling pipeline to discover safer alternatives from the Red Sea sponge Hyrtios erectus. We screened a comprehensive library of 8415 COX2-related records using four machine learning algorithms, identifying a random forest model (93% accuracy, 86% MCC) as the most robust predictor. Using this model to screen H. erectus-derived scalarane sesterterpenes, we identified four primary hits. Subsequent molecular docking and 100 ns explicit molecular dynamics simulations revealed that two leads, sesterstatin 7 and 24α-methoxypetrosaspongia C, exhibit superior affinities and thermodynamic stability within the COX2 catalytic site. Notably, these compounds achieve selectivity by targeting the COX2-exclusive hydrophilic side pocket, a feature absent in the COX1 isoform. These findings provide a high-impact foundation for lead optimization, offering a potential socio-economic breakthrough in the development of cost-effective, safer anti-inflammatory therapeutics derived from marine biodiversity.

View source

Similar papers

Open access Sep 2026

Discovery of PIM-1 kinase inhibitors from marine natural products through machine learning and structure-based screening

These findings identified CMNPD11687 as a promising marine-derived scaffold for PIM-1 inhibition and demonstrated the value of combining ML-driven screening with molecular simulation to accelerate early-stage anticancer drug discovery.

Bishal Budha, Arjun Acharya, Madan Khanal et al. · 0 citations
Sep 2026

Natural Product‐Derived ErbB1 Inhibitors Identified Through Machine Learning‐Based QSAR, Molecular Docking, and Molecular Dynamics Simulations

This work developed an integrated computational strategy to identify novel natural product‐derived ErbB1 inhibitors and provides a scalable computational framework to support future experimental validation and lead optimization.

F. Bouchama, A. Djerourou, Abdelmalek Khorief Nacereddine et al. · 0 citations
Review Sep 2026

Artificial Intelligence-Based Halogenated Chalcone Drug Discovery: An Integrated Framework for Rational Anticancer Lead Optimization

Halogenated chalcones are emerging as an exciting class of potential anticancer scaffolds with respect to medicinal chemistry; they exhibit structural flexibility, multitarget pharmacology, and allow for rapid medicinal chemistry optimization. The biological activity associated with halogen substitutions on the scaffol...

Tamara Bassam Kamal Hijjawi · 0 citations
Sep 2026

Interpretable Machine Learning for Structure–Activity Relationship Modeling of Cyclooxygenase-1 Inhibitors

An interpretable computational framework is developed for modeling COX-1 inhibitor activity and characterizing prioritized compounds at the molecular level by integrating QSAR modeling, explainable artificial intelligence, molecular docking, molecular dynamics, and MM/GBSA calculations to investigate COX-1 inhibitors.

Hamid Bouseber, Mustapha Cherkaoui · 0 citations
Open access Sep 2026

Artificial Intelligence and Virtual Screening to Identify Small Molecules Inhibiting Transglutaminase 2 for Investigation and Treatment of Breast Cancer

Artificial intelligence‐assisted virtual screening enables identification of chemically diverse bioactive small molecules. We targeted transglutaminase 2 (TG2), a multifunctional protein associated with mesenchymal‐like features in breast cancer. Approximately 10 million compounds were screened against the catalytic si...

Carlo M. Bergamini, Niel M. Henriksen, Brianna Ryan et al. · 0 citations
Sep 2026

Machine Learning Driven Discovery of Anticancer Phytochemicals from Medicinal Plants: A Computational Approach

Natural products remain an important source of chemically diverse molecules for anticancer drug discovery, but the large number of compounds reported in natural product databases makes systematic experimental screening difficult. Computational approaches can assist this process by identifying structural patterns associ...

H. Shaheen · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.